カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Aflibercept Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19108）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19108
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アフリベルセプト薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアフリベルセプト薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アフリベルセプト薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・プレフィルドシリンジ包装、バイアル包装

用途別セグメントは次のように区分されます。
・眼病、がん

世界のアフリベルセプト薬市場の主要な市場プレーヤーは以下のとおりです。
・Regeneron、Bayer、Sanofi

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アフリベルセプト薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアフリベルセプト薬メーカーの企業概要、2019年～2022年までのアフリベルセプト薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアフリベルセプト薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アフリベルセプト薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアフリベルセプト薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアフリベルセプト薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアフリベルセプト薬の産業チェーンを掲載しています。
・第13、14、15章では、アフリベルセプト薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アフリベルセプト薬の概要
- 種類別分析（2017年vs2021年vs2028年）：プレフィルドシリンジ包装、バイアル包装
- 用途別分析（2017年vs2021年vs2028年）：眼病、がん
- 世界のアフリベルセプト薬市場規模・予測
- 世界のアフリベルセプト薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Regeneron、Bayer、Sanofi
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：プレフィルドシリンジ包装、バイアル包装
・用途別分析2017年-2028年：眼病、がん
・アフリベルセプト薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アフリベルセプト薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アフリベルセプト薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アフリベルセプト薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アフリベルセプト薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Aflibercept Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Aflibercept Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Eye Disease accounting for % of the Aflibercept Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prefilled Syring Package segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Aflibercept Drug include Regeneron, Bayer, Sanofi, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Aflibercept Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prefilled Syring Package
Vial Package
Market segment by Application can be divided into
Eye Disease
Cancer
The key market players for global Aflibercept Drug market are listed below:
Regeneron
Bayer
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aflibercept Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aflibercept Drug, with price, sales, revenue and global market share of Aflibercept Drug from 2019 to 2022.
Chapter 3, the Aflibercept Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aflibercept Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Aflibercept Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Aflibercept Drug.
Chapter 13, 14, and 15, to describe Aflibercept Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Aflibercept Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aflibercept Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prefilled Syring Package
1.2.3 Vial Package
1.3 Market Analysis by Application
1.3.1 Overview: Global Aflibercept Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Eye Disease
1.3.3 Cancer
1.4 Global Aflibercept Drug Market Size & Forecast
1.4.1 Global Aflibercept Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Aflibercept Drug Sales in Volume (2017-2028)
1.4.3 Global Aflibercept Drug Price (2017-2028)
1.5 Global Aflibercept Drug Production Capacity Analysis
1.5.1 Global Aflibercept Drug Total Production Capacity (2017-2028)
1.5.2 Global Aflibercept Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Aflibercept Drug Market Drivers
1.6.2 Aflibercept Drug Market Restraints
1.6.3 Aflibercept Drug Trends Analysis
2 Manufacturers Profiles
2.1 Regeneron
2.1.1 Regeneron Details
2.1.2 Regeneron Major Business
2.1.3 Regeneron Aflibercept Drug Product and Services
2.1.4 Regeneron Aflibercept Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Aflibercept Drug Product and Services
2.2.4 Bayer Aflibercept Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Aflibercept Drug Product and Services
2.3.4 Sanofi Aflibercept Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Aflibercept Drug Breakdown Data by Manufacturer
3.1 Global Aflibercept Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Aflibercept Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Aflibercept Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Aflibercept Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Aflibercept Drug Manufacturer Market Share in 2021
3.5 Global Aflibercept Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Aflibercept Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Aflibercept Drug Market Size by Region
4.1.1 Global Aflibercept Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Aflibercept Drug Revenue by Region (2017-2028)
4.2 North America Aflibercept Drug Revenue (2017-2028)
4.3 Europe Aflibercept Drug Revenue (2017-2028)
4.4 Asia-Pacific Aflibercept Drug Revenue (2017-2028)
4.5 South America Aflibercept Drug Revenue (2017-2028)
4.6 Middle East and Africa Aflibercept Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Aflibercept Drug Sales in Volume by Type (2017-2028)
5.2 Global Aflibercept Drug Revenue by Type (2017-2028)
5.3 Global Aflibercept Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Aflibercept Drug Sales in Volume by Application (2017-2028)
6.2 Global Aflibercept Drug Revenue by Application (2017-2028)
6.3 Global Aflibercept Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Aflibercept Drug Sales by Type (2017-2028)
7.2 North America Aflibercept Drug Sales by Application (2017-2028)
7.3 North America Aflibercept Drug Market Size by Country
7.3.1 North America Aflibercept Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Aflibercept Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Aflibercept Drug Sales by Type (2017-2028)
8.2 Europe Aflibercept Drug Sales by Application (2017-2028)
8.3 Europe Aflibercept Drug Market Size by Country
8.3.1 Europe Aflibercept Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Aflibercept Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Aflibercept Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Aflibercept Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Aflibercept Drug Market Size by Region
9.3.1 Asia-Pacific Aflibercept Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Aflibercept Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Aflibercept Drug Sales by Type (2017-2028)
10.2 South America Aflibercept Drug Sales by Application (2017-2028)
10.3 South America Aflibercept Drug Market Size by Country
10.3.1 South America Aflibercept Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Aflibercept Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Aflibercept Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Aflibercept Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Aflibercept Drug Market Size by Country
11.3.1 Middle East & Africa Aflibercept Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Aflibercept Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Aflibercept Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Aflibercept Drug
12.3 Aflibercept Drug Production Process
12.4 Aflibercept Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Aflibercept Drug Typical Distributors
13.3 Aflibercept Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Aflibercept Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Aflibercept Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Regeneron Basic Information, Manufacturing Base and Competitors
Table 4. Regeneron Major Business
Table 5. Regeneron Aflibercept Drug Product and Services
Table 6. Regeneron Aflibercept Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Aflibercept Drug Product and Services
Table 10. Bayer Aflibercept Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Aflibercept Drug Product and Services
Table 14. Sanofi Aflibercept Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global Aflibercept Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global Aflibercept Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in Aflibercept Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global Aflibercept Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Aflibercept Drug Production Site of Key Manufacturer
Table 20. Aflibercept Drug New Entrant and Capacity Expansion Plans
Table 21. Aflibercept Drug Mergers & Acquisitions in the Past Five Years
Table 22. Global Aflibercept Drug Sales by Region (2017-2022) & (K Units)
Table 23. Global Aflibercept Drug Sales by Region (2023-2028) & (K Units)
Table 24. Global Aflibercept Drug Revenue by Region (2017-2022) & (USD Million)
Table 25. Global Aflibercept Drug Revenue by Region (2023-2028) & (USD Million)
Table 26. Global Aflibercept Drug Sales by Type (2017-2022) & (K Units)
Table 27. Global Aflibercept Drug Sales by Type (2023-2028) & (K Units)
Table 28. Global Aflibercept Drug Revenue by Type (2017-2022) & (USD Million)
Table 29. Global Aflibercept Drug Revenue by Type (2023-2028) & (USD Million)
Table 30. Global Aflibercept Drug Price by Type (2017-2022) & (US$/Unit)
Table 31. Global Aflibercept Drug Price by Type (2023-2028) & (US$/Unit)
Table 32. Global Aflibercept Drug Sales by Application (2017-2022) & (K Units)
Table 33. Global Aflibercept Drug Sales by Application (2023-2028) & (K Units)
Table 34. Global Aflibercept Drug Revenue by Application (2017-2022) & (USD Million)
Table 35. Global Aflibercept Drug Revenue by Application (2023-2028) & (USD Million)
Table 36. Global Aflibercept Drug Price by Application (2017-2022) & (US$/Unit)
Table 37. Global Aflibercept Drug Price by Application (2023-2028) & (US$/Unit)
Table 38. North America Aflibercept Drug Sales by Country (2017-2022) & (K Units)
Table 39. North America Aflibercept Drug Sales by Country (2023-2028) & (K Units)
Table 40. North America Aflibercept Drug Revenue by Country (2017-2022) & (USD Million)
Table 41. North America Aflibercept Drug Revenue by Country (2023-2028) & (USD Million)
Table 42. North America Aflibercept Drug Sales by Type (2017-2022) & (K Units)
Table 43. North America Aflibercept Drug Sales by Type (2023-2028) & (K Units)
Table 44. North America Aflibercept Drug Sales by Application (2017-2022) & (K Units)
Table 45. North America Aflibercept Drug Sales by Application (2023-2028) & (K Units)
Table 46. Europe Aflibercept Drug Sales by Country (2017-2022) & (K Units)
Table 47. Europe Aflibercept Drug Sales by Country (2023-2028) & (K Units)
Table 48. Europe Aflibercept Drug Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe Aflibercept Drug Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe Aflibercept Drug Sales by Type (2017-2022) & (K Units)
Table 51. Europe Aflibercept Drug Sales by Type (2023-2028) & (K Units)
Table 52. Europe Aflibercept Drug Sales by Application (2017-2022) & (K Units)
Table 53. Europe Aflibercept Drug Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific Aflibercept Drug Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific Aflibercept Drug Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific Aflibercept Drug Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific Aflibercept Drug Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific Aflibercept Drug Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific Aflibercept Drug Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific Aflibercept Drug Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific Aflibercept Drug Sales by Application (2023-2028) & (K Units)
Table 62. South America Aflibercept Drug Sales by Country (2017-2022) & (K Units)
Table 63. South America Aflibercept Drug Sales by Country (2023-2028) & (K Units)
Table 64. South America Aflibercept Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. South America Aflibercept Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. South America Aflibercept Drug Sales by Type (2017-2022) & (K Units)
Table 67. South America Aflibercept Drug Sales by Type (2023-2028) & (K Units)
Table 68. South America Aflibercept Drug Sales by Application (2017-2022) & (K Units)
Table 69. South America Aflibercept Drug Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa Aflibercept Drug Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa Aflibercept Drug Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa Aflibercept Drug Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa Aflibercept Drug Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa Aflibercept Drug Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa Aflibercept Drug Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa Aflibercept Drug Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa Aflibercept Drug Sales by Application (2023-2028) & (K Units)
Table 78. Aflibercept Drug Raw Material
Table 79. Key Manufacturers of Aflibercept Drug Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Aflibercept Drug Typical Distributors
Table 83. Aflibercept Drug Typical Customers
List of Figures
Figure 1. Aflibercept Drug Picture
Figure 2. Global Aflibercept Drug Revenue Market Share by Type in 2021
Figure 3. Prefilled Syring Package
Figure 4. Vial Package
Figure 5. Global Aflibercept Drug Revenue Market Share by Application in 2021
Figure 6. Eye Disease
Figure 7. Cancer
Figure 8. Global Aflibercept Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Aflibercept Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Aflibercept Drug Sales (2017-2028) & (K Units)
Figure 11. Global Aflibercept Drug Price (2017-2028) & (US$/Unit)
Figure 12. Global Aflibercept Drug Production Capacity (2017-2028) & (K Units)
Figure 13. Global Aflibercept Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Aflibercept Drug Market Drivers
Figure 15. Aflibercept Drug Market Restraints
Figure 16. Aflibercept Drug Market Trends
Figure 17. Global Aflibercept Drug Sales Market Share by Manufacturer in 2021
Figure 18. Global Aflibercept Drug Revenue Market Share by Manufacturer in 2021
Figure 19. Aflibercept Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Aflibercept Drug Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Aflibercept Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Aflibercept Drug Sales Market Share by Region (2017-2028)
Figure 23. Global Aflibercept Drug Revenue Market Share by Region (2017-2028)
Figure 24. North America Aflibercept Drug Revenue (2017-2028) & (USD Million)
Figure 25. Europe Aflibercept Drug Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Aflibercept Drug Revenue (2017-2028) & (USD Million)
Figure 27. South America Aflibercept Drug Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Aflibercept Drug Revenue (2017-2028) & (USD Million)
Figure 29. Global Aflibercept Drug Sales Market Share by Type (2017-2028)
Figure 30. Global Aflibercept Drug Revenue Market Share by Type (2017-2028)
Figure 31. Global Aflibercept Drug Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Aflibercept Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Aflibercept Drug Revenue Market Share by Application (2017-2028)
Figure 34. Global Aflibercept Drug Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Aflibercept Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Aflibercept Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Aflibercept Drug Sales Market Share by Country (2017-2028)
Figure 38. North America Aflibercept Drug Revenue Market Share by Country (2017-2028)
Figure 39. United States Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Aflibercept Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Aflibercept Drug Sales Market Share by Application (2017-2028)
Figure 44. Europe Aflibercept Drug Sales Market Share by Country (2017-2028)
Figure 45. Europe Aflibercept Drug Revenue Market Share by Country (2017-2028)
Figure 46. Germany Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Aflibercept Drug Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Aflibercept Drug Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Aflibercept Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Aflibercept Drug Revenue Market Share by Region (2017-2028)
Figure 55. China Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Aflibercept Drug Sales Market Share by Type (2017-2028)
Figure 62. South America Aflibercept Drug Sales Market Share by Application (2017-2028)
Figure 63. South America Aflibercept Drug Sales Market Share by Country (2017-2028)
Figure 64. South America Aflibercept Drug Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Aflibercept Drug Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Aflibercept Drug Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Aflibercept Drug Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Aflibercept Drug Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Aflibercept Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Aflibercept Drug in 2021
Figure 76. Manufacturing Process Analysis of Aflibercept Drug
Figure 77. Aflibercept Drug Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界の軟骨形成術治療薬市場2022年：市場規模予測（～2028年）
  • 世界の3Dプリンター製医薬品市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19108 )"世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）" (英文：Global Aflibercept Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。